-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
-
Summary
-
Nuvectis Pharma, Inc. quarterly Deferred Tax Assets, Net of Valuation Allowance history and change rate from Q4 2022 to Q4 2024.
- Nuvectis Pharma, Inc. Deferred Tax Assets, Net of Valuation Allowance for the quarter ending 31 Dec 2024 was $0.
Deferred Tax Assets, Net of Valuation Allowance, Quarterly (USD)